(ECNS) -- "After February 2022, with the arrival of new variants of the virus imported from abroad, China was able to face several localized outbreaks, control them and progressively reduce their impact and morbidity", said Rui Lourido, director of China Observation Institute in Portugal.
In his opinion, as vaccination was widespread and reinforced with new doses and the emergence of proven effective drugs, which changed the population's ability to protect themselves autonomously and overcome the disease and its danger and morbidity, China adjusted its COVID policy scientifically.